Jop P. Mostert

Arnhem, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

Journal: Neurology

Published: June 18, 2026

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders

Published: April 30, 2026

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 20, 2026

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.

Journal: European journal of neurology

Published: March 19, 2026

The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.

The practice effect of smartphone-derived cognitive processing speed assessments as a proxy of cognitive functioning in multiple sclerosis.

Journal: Journal of neurology

Published: February 19, 2026

Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 04, 2025

Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: July 16, 2025

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Reliability of serum neurofilament light and glial fibrillary acidic protein for detecting disease activity upon discontinuation of first-line disease-modifying therapy in stable multiple sclerosis (DOT-MS).

Journal: Journal of neurology

Published: June 16, 2025

Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.

Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 13, 2025

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Cognitive test performance and disease progression in primary and secondary progressive MS: An analysis of the SPRINT-MS study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 08, 2025

Evaluating the effect of cannabidiol on sleep quality in patients with multiple sclerosis using 15 aggregated N-of-1 trials: A study protocol.

Evaluating the effect of cannabidiol on sleep quality in patients with multiple sclerosis using 15 aggregated N-of-1 trials: A study protocol.

Journal: Contemporary clinical trials

Published: May 06, 2025

Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.

Prescriptions and healthcare use in multiple sclerosis patients within general practices in the Netherlands.

Journal: Multiple sclerosis and related disorders

Published: April 24, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026